Start-up & SME
Discusses the impact of limited market size on epilepsy therapies and shows how an early-stage venture fund can catalyze faster development of new treatments.
Illustrates potential market failures for new drug development in epilepsy market and shows novel organizational vehicle to commercialize greater innovation from epilepsy research.
Pub Date: Feb 8, 2002
Discipline: Operations Management
Subjects: Corporate social responsibility, Innovation, Technology, Venture capital
Source: Harvard Business School
Product #: 602124-PDF-ENG
Teaching note: Not available
Geography: United States
Length: 22 page(s)
Commercialization of technology